工业级3D打印设备

Search documents
易加增材赴科创板上市获受理 应收账款占营收比重近半
Zhong Guo Jing Ying Bao· 2025-08-20 13:15
Core Viewpoint - The company, Yijia Additive Manufacturing Technology Co., Ltd., has recently had its IPO application accepted on the Sci-Tech Innovation Board, aiming to raise approximately 12.05 billion yuan for four new projects with a total investment of about 13.38 billion yuan [1]. Financial Performance - The company has shown consistent growth in revenue, net profit, and assets from 2022 to 2024, with total revenues of 2.47 billion yuan, 4.09 billion yuan, and 4.71 billion yuan respectively, reflecting year-on-year growth rates of 65.42% and 15.22% for 2023 and 2024 [2]. - The net profit after deducting non-recurring items is projected to increase significantly, with figures of 0.25 billion yuan, 0.69 billion yuan, and 0.93 billion yuan for the same period, indicating growth rates of 179.26% and 34.74% for 2023 and 2024 [2]. - The company's total liabilities decreased from 5.16 billion yuan in 2022 to 2.61 billion yuan in 2024, resulting in a declining debt ratio from 82.63% to 16.69% [2]. Accounts Receivable - Accounts receivable have grown rapidly, with figures of 0.74 billion yuan, 1.38 billion yuan, and 1.95 billion yuan from 2022 to 2024, representing 33.30%, 37.68%, and 46.04% of total revenue respectively [3]. - By the end of 2024, accounts receivable over one year old amounted to 0.75 billion yuan, accounting for 34.59% of the total, indicating some long-term receivables have not been fully recovered [3]. Inventory Management - The company's inventory has also increased, with total inventory values of 2.68 billion yuan, 3.75 billion yuan, and 4.45 billion yuan from 2022 to 2024, with inventory levels in 2024 being comparable to annual revenue [3]. - The balance of finished goods inventory has risen significantly, with values of 0.37 billion yuan, 0.94 billion yuan, and 1.56 billion yuan, reflecting a growing proportion of 13.79%, 24.71%, and 34.53% respectively [4]. Cash Flow Analysis - The company has experienced negative net cash flow from operating activities over the three years, with figures of -1.06 billion yuan, 0.20 billion yuan, and -0.94 billion yuan [5]. - Cash inflows from sales have increased, but outflows have risen at a faster rate due to growing inventory and accounts receivable [6]. Research and Development - The company has been increasing its R&D expenditures, which were 0.21 billion yuan, 0.24 billion yuan, and 0.31 billion yuan over the three years, representing 8.57%, 5.82%, and 6.50% of total revenue [7][8]. - As of the end of 2024, the company had 123 domestic authorized patents, including 49 invention patents, indicating a strong focus on innovation [8]. Ownership Structure - The controlling shareholder, Yongsheng Holdings, holds a 30.64% stake in the company, with the actual controllers being Li Cheng and Li Jianhao, who collectively control 54.53% of the voting rights [9][10][11].
“三高四新”擘画卷 创新潮涌满湘江——湖南上市公司转型升级样本调研
Shang Hai Zheng Quan Bao· 2025-08-12 19:15
Group 1: Blue Glass Technology - Blue Glass Technology officially listed on the Hong Kong Stock Exchange on July 9, 2025, marking a significant milestone in its globalization strategy [8][14] - The company has invested 18 billion yuan over ten years, resulting in over 2,200 authorized patents, showcasing its commitment to innovation [13][34] - Blue Glass has transitioned from manufacturing mobile phone glass to becoming a leading supplier in the smart hardware sector, including AI glasses and robotics [19][21] Group 2: Warner Pharmaceutical - Warner Pharmaceutical, primarily focused on generic drugs, reported a revenue of over 1.4 billion yuan in 2024, with R&D investment reaching 158 million yuan, accounting for 11.21% of its revenue [26][34] - The company is transitioning from a generic drug manufacturer to an innovative pharmaceutical enterprise, focusing on niche markets such as depression and rare animal medicine substitutes [27][33] - Warner Pharmaceutical has established a strong production base with over 80 drug registration approvals, aiming to enhance its competitive edge in the pharmaceutical industry [29][30] Group 3: Xue Tian Salt Industry - Xue Tian Salt Industry, known as China's first salt reform stock, is expanding from traditional salt production to new energy materials, including sodium batteries and fiber materials [38][39] - The company aims to achieve total assets exceeding 10 billion yuan and brand value of 11.8 billion yuan, with a strategic focus on becoming a leading salt chemical enterprise [36][41] - Xue Tian is investing in a fiber research institute to explore the mass production of fiber electronic devices, further diversifying its business [40][41] Group 4: Huashu High-Tech - Huashu High-Tech has developed a complete industrial-grade additive manufacturing technology system, focusing on 3D printing applications across various industries [42][48] - The company has achieved significant growth, with over 1,200 units of its 3D printing equipment sold globally, and is actively expanding its R&D capabilities [48][49] - Huashu High-Tech emphasizes the importance of innovation and focus in overcoming challenges in the 3D printing industry, positioning itself for future market growth [47][49]
GPU“四小龙”摩尔线程申报在即,中科创新创业板折戟十年后转战科创板 | IPO
Sou Hu Cai Jing· 2025-06-25 13:35
Group 1: Companies Submitting IPO Counseling Reports - Tianjin Aisida Aerospace Technology Co., Ltd. submitted an IPO counseling report to Tianjin Securities Regulatory Bureau on June 16, aiming to list on the Shanghai Stock Exchange's Sci-Tech Innovation Board [3][4] - Wuhan Zhongke Innovation Technology Co., Ltd. submitted an IPO counseling report to Hubei Securities Regulatory Bureau on June 17, also targeting the Shanghai Stock Exchange's Sci-Tech Innovation Board [6][7] - Suzhou Xinnowei Pharmaceutical Technology Co., Ltd. submitted an IPO counseling report to Jiangsu Securities Regulatory Bureau on June 17, with no specific listing board determined yet [11][12] Group 2: Companies Passing IPO Counseling Acceptance - Xinqiang Electronics (Qingyuan) Co., Ltd. passed the counseling acceptance on June 17, specializing in the research, production, and sales of printed circuit boards [15][16] - Guangdong Kueri Sui Numerical Control Technology Co., Ltd. passed the counseling acceptance on June 17, focusing on the production and sales of CNC machine tools [17] - Maitian Energy Co., Ltd. passed the counseling acceptance on June 18, engaged in the research, production, and sales of solar inverters and energy storage systems [18][19] - Moer Thread Intelligent Technology (Beijing) Co., Ltd. passed the counseling acceptance on June 18, specializing in GPU chip design [20] - Hangzhou Yijia 3D Additive Technology Co., Ltd. passed the counseling acceptance on June 18, focusing on industrial-grade 3D printing equipment [22] Group 3: Company Financing Activities - Aisida has completed 10 financing rounds since its first angel round in 2018, with notable investors including Zhongxin Rongchuang and Lushi Investment [4] - Zhongke Innovation has a large customer base including major companies like Xi'an Aerospace and BYD [9][10] - Xinnowei has raised funds through 8 financing rounds since its first Pre-A round in 2017, with investors including Tencent and various venture capital firms [11][12] - Kueri Sui has completed 8 financing rounds since its angel round in 2016, with investors including Lichong Investment and Dinghui Baifu [17] - Maitian Energy has secured 3 rounds of financing since its establishment in 2019, with the latest round exceeding 1 billion yuan [18][19] - Moer Thread has received 7 rounds of financing, with notable investors including Sequoia China and Tencent [20]